Roche has announced that it will invest $50 billion into the United States in the next five years. The investments build on the company’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions. They are expected to create more than 12,000 new jobs, including nearly 6,500 construction […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!